Phosphorylated tau and the neurodegenerative foldopathies

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1739, Issue 2, 2005, Pages 298-310

  Kosik, Kenneth S ^a   Shimura, Hideki ^b  

^a HARVARD INSTITUTES OF MEDICINE   (United States)

^b NONE

Author keywords

Cdk5 and GSK3 beta; CHIP; Hsc70; Hsp27; Phosphorylated tau

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CHAPERONE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE 5; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK COGNATE PROTEIN 70; HEAT SHOCK PROTEIN 27; LACTACYSTIN; LIGASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; PROTEIN KINASE C; TAU PROTEIN;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL DEATH; CELL INCLUSION; CELL PROTECTION; CELL VIABILITY; DNA FLANKING REGION; ENZYME ACTIVATION; ENZYME INHIBITION; EXON; FRONTAL CORTEX; GENE MUTATION; GENETIC CODE; HUMAN; MICROTUBULE; NERVE DEGENERATION; NONHUMAN; PAIRED HELICAL FILAMENT; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; UBIQUITINATION;

ANIMALS; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INCLUSION BODIES; MOLECULAR CHAPERONES; MUTATION; NERVE DEGENERATION; PHOSPHORYLATION; PROTEIN FOLDING; TAU PROTEINS; TAUOPATHIES; UBIQUITIN;

HARNESS;

EID: 10944273982     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2004.10.011     Document Type: Review

References (137)

1. J. Magrane, R.C. Smith, K. Walsh, and H.W. Querfurth Heat shock protein 70 participates in the neuroprotective response to intracellularly expressed beta-amyloid in neurons J. Neurosci. 24 2004 1700 1706
2. J.N. Buxbaum The systemic amyloidoses Curr. Opin. Rheumatol. 16 2004 67 75
3. T. Revesz, J. Ghiso, T. Lashley, G. Plant, A. Rostagno, B. Frangione, and J.L. Holton Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view J. Neuropathol. Exp. Neurol. 62 2003 885 898
4. C.P. Donahue, and K.S. Kosik Distribution pattern of Notch3 mutations suggests a gain-of-function mechanism for CADASIL Genomics 83 2004 59 65
5. K.A. Sieradzan, A.O. Mechan, L. Jones, E.E. Wanker, N. Nukina, and D.M. Mann Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein Exp. Neurol. 156 1999 92 99
6. J.S. Steffan, N. Agrawal, J. Pallos, E. Rockabrand, L.C. Trotman, N. Slepko, K. Illes, T. Lukacsovich, Y.Z. Zhu, E. Cattaneo, P.P. Pandolfi, L.M. Thompson, and J.L. Marsh SUMO modification of Huntingtin and Huntington's disease pathology Science 304 2004 100 104
7. J.M. Warrick, H.Y. Chan, G.L. Gray-Board, Y. Chai, H.L. Paulson, and N.M. Bonini Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70 Nat. Genet. 23 1999 425 428
8. C.J. Cummings, Y. Sun, P. Opal, B. Antalffy, R. Mestril, H.T. Orr, W.H. Dillmann, and H.Y. Zoghbi Overexpression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice Hum. Mol. Genet. 10 2001 1511 15118
9. P. Fernandez-Funez, M.L. Nino-Rosales, B. de Gouyon, W.C. She, J.M. Luchak, P. Martinez, E. Turiegano, J. Benito, M. Capovilla, P.J. Skinner, A. McCall, I. Canal, H.T. Orr, H.Y. Zoghbi, and J. Botas Identification of genes that modify ataxin-1-induced neurodegeneration Nature 408 2000 101 106
10. C.J. Cummings, E. Reinstein, Y. Sun, B. Antalffy, Y. Jiang, A. Ciechanover, H.T. Orr, A.L. Beaudet, and H.Y. Zoghbi Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice Neuron 24 1999 879 892
11. K. Watase, E.J. Weeber, B. Xu, B. Antalffy, L. Yuva-Paylor, K. Hashimoto, M. Kano, R. Atkinson, Y. Sun, D.L. Armstrong, J.D. Sweatt, H.T. Orr, R. Paylor, and H.Y. Zoghbi A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration Neuron 34 2002 905 919
12. T. Shimohata, T. Nakajima, M. Yamada, C. Uchida, O. Onodera, S. Naruse, T. Kimura, R. Koide, K. Nozaki, Y. Sano, H. Ishiguro, K. Sakoe, T. Ooshima, A. Sato, T. Ikeuchi, M. Oyake, T. Sato, Y. Aoyagi, I. Hozumi, T. Nagatsu, Y. Takiyama, M. Nishizawa, J. Goto, I. Kanazawa, I. Davidson, N. Tanese, H. Takahashi, and S. Tsuji Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription Nat. Genet. 26 2000 29 36
13. J.M. Boutell, P. Thomas, J.W. Neal, V.J. Weston, J. Duce, P.S. Harper, and A.L. Jones Aberrant interactions of transcriptional repressor proteins with the Huntington's disease gene product, huntingtin Hum. Mol. Genet. 8 1999 1647 1655
14. J.S. Steffan, A. Kazantsev, O. Spasic-Boskovic, M. Greenwald, Y.Z. Zhu, H. Gohler, E.E. Wanker, G.P. Bates, D.E. Housman, and L.M. Thompson The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription Proc. Natl. Acad. Sci. U. S. A. 97 2000 6763 6768
15. A. McCampbell, J.P. Taylor, A.A. Taye, J. Robitschek, M. Li, J. Walcott, D. Merry, Y. Chai, H. Paulson, G. Sobue, and K.H. Fischbeck CREB-binding protein sequestration by expanded polyglutamine Hum. Mol. Genet. 9 2000 2197 2202
16. F.C. Nucifora Jr., M. Sasaki, M.F. Peters, H. Huang, J.K. Cooper, M. Yamada, H. Takahashi, S. Tsuji, J. Troncoso, V.L. Dawson, T.M. Dawson, and C.A. Ross Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity Science 291 2001 2423 2428
17. G. Yvert, K.S. Lindenberg, D. Devys, D. Helmlinger, G.B. Landwehrmeyer, and J.L. Mandel SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types Hum. Mol. Genet. 10 2001 1679 1692
18. P. Pasinelli, M.E. Belford, N. Lennon, B.J. Bacskai, B.T. Hyman, D. Trotti, and R.H. Brown Jr. Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria Neuron 43 2004 19 30
19. V.L. Gabai, A.B. Meriin, D.D. Mosser, A.W. Caron, S. Rits, V.I. Shifrin, and M.Y. Sherman Hsp70 prevents activation of stress kinases. A novel pathway of cellular thermotolerance J. Biol. Chem. 272 1997 18033 18037
20. D.D. Mosser, A.W. Caron, L. Bourget, A.B. Meriin, M.Y. Sherman, R.I. Morimoto, and B. Massie The chaperone function of hsp70 is required for protection against stress-induced apoptosis Mol. Cell. Biol. 20 2000 7146 7159
21. H. Zhou, S.H. Li, and X.J. Li Chaperone suppression of cellular toxicity of huntingtin is independent of polyglutamine aggregation J. Biol. Chem. 276 2001 48417 48424
22. M. Baba, S. Nakajo, P.H. Tu, T. Tomita, K. Nakaya, V.M. Lee, J.Q. Trojanowski, and T. Iwatsubo Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies Am. J. Pathol. 152 1998 879 884
23. M.G. Spillantini, M.L. Schmidt, V.M. Lee, J.Q. Trojanowski, R. Jakes, and M. Goedert Alpha-synuclein in Lewy bodies Nature 388 1997 839 840
24. L.P. Lim, M.E. Glasner, S. Yekta, C.B. Burge, and D.P. Bartel Vertebrate microRNA genes Science 299 2003 1540
25. S. Kuzuhara, H. Mori, N. Izumiyama, M. Yoshimura, and Y. Ihara Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study Acta Neuropathol. (Berl) 75 1988 345 353
26. A. Ciechanover Linking ubiquitin, parkin and synphilin-1 Nat. Med. 7 2001 1108 1109
27. H. Shimura, N. Hattori, S. Kubo, M. Yoshikawa, T. Kitada, H. Matsumine, S. Asakawa, S. Minoshima, Y. Yamamura, N. Shimizu, and Y. Mizuno Immunohistochemical and subcellular localization of Parkin protein: absence of protein in autosomal recessive juvenile parkinsonism patients Ann. Neurol. 45 1999 668 672
28. P.K. Auluck, H.Y. Chan, J.Q. Trojanowski, V.M. Lee, and N.M. Bonini Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease Science 295 2002 865 868
29. H. Shimura, M.G. Schlossmacher, N. Hattori, M.P. Frosch, A. Trockenbacher, R. Schneider, Y. Mizuno, K.S. Kosik, and D.J. Selkoe Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease Science 293 2001 263 269
30. Y. Zhang, J. Gao, K.K. Chung, H. Huang, V.L. Dawson, and T.M. Dawson Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1 Proc. Natl. Acad. Sci. U. S. A. 97 2000 13354 13359
31. Y. Imai, M. Soda, H. Inoue, N. Hattori, Y. Mizuno, and R. Takahashi An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin Cell 105 2001 891 902
32. K.K. Chung, Y. Zhang, K.L. Lim, Y. Tanaka, H. Huang, J. Gao, C.A. Ross, V.L. Dawson, and T.M. Dawson Parkin ubiquitinates the alpha-synuclein- interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease Nat. Med. 7 2001 1144 1150
33. D.M. Maraganore, T.G. Lesnick, A. Elbaz, M.C. Chartier-Harlin, T. Gasser, R. Kruger, N. Hattori, G.D. Mellick, A. Quattrone, J. Satoh, T. Toda, J. Wang, J.P. Ioannidis, M. de Andrade, and W.A. Rocca UCHL1 is a Parkinson's disease susceptibility gene Ann. Neurol. 55 2004 512 521
34. E.R. Martin, W.K. Scott, M.A. Nance, R.L. Watts, J.P. Hubble, W.C. Koller, K. Lyons, R. Pahwa, M.B. Stern, A. Colcher, B.C. Hiner, J. Jankovic, W.G. Ondo, F.H. Allen Jr., C.G. Goetz, G.W. Small, D. Masterman, F. Mastaglia, N.G. Laing, J.M. Stajich, R.C. Ribble, M.W. Booze, A. Rogala, M.A. Hauser, F. Zhang, R.A. Gibson, L.T. Middleton, A.D. Roses, J.L. Haines, B.L. Scott, M.A. Pericak-Vance, and J.M. Vance Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease JAMA 286 2001 2245 2250
35. J.B. Kwok, E.T. Teber, C. Loy, M. Hallupp, G. Nicholson, G.D. Mellick, D.D. Buchanan, P.A. Silburn, and P.R. Schofield Tau haplotypes regulate transcription and are associated with Parkinson's disease Ann. Neurol. 55 2004 329 334
36. J.E. Duda, B.I. Giasson, M.E. Mabon, D.C. Miller, L.I. Golbe, V.M. Lee, and J.Q. Trojanowski Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred Acta Neuropathol. (Berl) 104 2002 7 11
37. B.I. Giasson, M.S. Forman, M. Higuchi, L.I. Golbe, C.L. Graves, P.T. Kotzbauer, J.Q. Trojanowski, and V.M. Lee Initiation and synergistic fibrillization of tau and alpha-synuclein Science 300 2003 636 640
38. M. Hutton, C.L. Lendon, P. Rizzu, M. Baker, S. Froelich, H. Houlden, S. Pickering-Brown, S. Chakraverty, A. Isaacs, A. Grover, J. Hackett, J. Adamson, S. Lincoln, D. Dickson, P. Davies, R.C. Petersen, M. Stevens, E. de Graaff, E. Wauters, J. van Baren, M. Hillebrand, M. Joosse, J.M. Kwon, P. Nowotny, L.K. Che, J. Norton, J.C. Morris, L.A. Reed, J. Trojanowski, H. Basun, L. Lannfelt, M. Neystat, S. Fahn, F. Dark, T. Tannenberg, P.R. Dodd, N. Hayward, J.B. Kwok, P.R. Schofield, A. Andreadis, J. Snowden, D. Craufurd, D. Neary, F. Owen, B.A. Oostra, J. Hardy, A. Goate, J. Van Swieten, D. Mann, T. Lynch, and P. Heutink Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 Nature 393 1998 702 705
39. P. Poorkaj, T.D. Bird, E. Wijsman, E. Nemens, R.M. Garruto, L. Anderson, A. Andreadis, W.C. Wiederholt, M. Raskind, and G.D. Schellenberg Tau is a candidate gene for chromosome 17 frontotemporal dementia [published erratum appears in Ann Neurol 1998 Sep;44(3):428] Ann. Neurol. 43 1998 815 825
40. M.G. Spillantini, J.R. Murrell, M. Goedert, M.R. Farlow, A. Klug, and B. Ghetti Mutation in the tau gene in familial multiple system tauopathy with presenile dementia Proc. Natl. Acad. Sci. U. S. A. 95 1998 7737 7741
41. M. Hasegawa, H. Fujiwara, T. Nonaka, K. Wakabayashi, H. Takahashi, V.M. Lee, J.Q. Trojanowski, D. Mann, and T. Iwatsubo Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions J. Biol. Chem. 277 2002 49071 49076
42. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, K. Titani, and Y. Ihara Ubiquitin is conjugated with amino-terminally processsed tau in paired helical filaments Neuron 10 1993 1151 1160
43. G.K. Tofaris, A. Razzaq, B. Ghetti, K. Lilley, and M.G. Spillantini Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function J. Biol. Chem. 15 2003 15
44. C.M. Pickart Ubiquitin in chains Trends Biochem. Sci. 25 2000 544 548
45. M.Y. Sherman, and A.L. Goldberg Cellular defenses against unfolded proteins: a cell biologist thinks about neurodegenerative diseases Neuron 29 2001 15 32
46. W. Baumeister, J. Walz, F. Zuhl, and E. Seemuller The proteasome: paradigm of a self-compartmentalizing protease Cell 92 1998 367 380
47. A. Hershko, and A. Ciechanover The ubiquitin system Annu. Rev. Biochem. 67 1998 425 479
48. J.S. Thrower, L. Hoffman, M. Rechsteiner, and C.M. Pickart Recognition of the polyubiquitin proteolytic signal EMBO J. 19 2000 94 102
49. R. Verma, S. Chen, R. Feldman, D. Schieltz, J. Yates, J. Dohmen, and R.J. Deshaies Proteasomal proteomics: identification of nucleotide-sensitive proteasome-interacting proteins by mass spectrometric analysis of affinity-purified proteasomes Mol. Biol. Cell 11 2000 3425 3439
50. S.A. Teter, W.A. Houry, D. Ang, T. Tradler, D. Rockabrand, G. Fischer, P. Blum, C. Georgopoulos, and F.U. Hartl Polypeptide flux through bacterial Hsp70: DnaK cooperates with trigger factor in chaperoning nascent chains Cell 97 1999 755 765
51. U. Schubert, L.C. Anton, J. Gibbs, C.C. Norbury, J.W. Yewdell, and J.R. Bennink Rapid degradation of a large fraction of newly synthesized proteins by proteasomes Nature 404 2000 770 774
52. C. Schneider, L. Sepp-Lorenzino, E. Nimmesgern, O. Ouerfelli, S. Danishefsky, N. Rosen, and F.U. Hartl Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90 Proc. Natl. Acad. Sci. U. S. A. 93 1996 14536 14541
53. N.F. Bence, R.M. Sampat, and R.R. Kopito Impairment of the ubiquitin-proteasome system by protein aggregation Science 292 2001 1552 1555
54. C.J. Cummings, M.A. Mancini, B. Antalffy, D.B. DeFranco, H.T. Orr, and H.Y. Zoghbi Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 Nat. Genet. 19 1998 148 154
55. Y.A. Lam, C.M. Pickart, A. Alban, M. Landon, C. Jamieson, R. Ramage, R.J. Mayer, and R. Layfield Inhibition of the ubiquitin-proteasome system in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 97 2000 9902 9906
56. K. Lindsten, F.M. de Vrij, L.G. Verhoef, D.F. Fischer, F.W. van Leeuwen, E.M. Hol, M.G. Masucci, and N.P. Dantuma Mutant ubiquitin found in neurodegenerative disorders is a ubiquitin fusion degradation substrate that blocks proteasomal degradation J. Cell Biol. 157 2002 417 427
57. Y. Mizuno, N. Hattori, H. Mori, T. Suzuki, and K. Tanaka Parkin and Parkinson's disease Curr. Opin. Neurol. 14 2001 477 482
58. C. Soto Protein misfolding and disease; protein refolding and therapy FEBS Lett. 498 2001 204 207
59. P.J. Muchowski Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron 35 2002 9 12
60. L.G. Verhoef, K. Lindsten, M.G. Masucci, and N.P. Dantuma Aggregate formation inhibits proteasomal degradation of polyglutamine proteins Hum. Mol. Genet. 11 2002 2689 2700
61. S. Willingham, T.F. Outeiro, M.J. DeVit, S.L. Lindquist, and P.J. Muchowski Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein Science 302 2003 1769 1772
62. H. Shimura, N. Hattori, S. Kubo, Y. Mizuno, S. Asakawa, S. Minoshima, N. Shimizu, K. Iwai, T. Chiba, K. Tanaka, and T. Suzuki Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase Nat. Genet. 25 2000 302 305
63. H. Mori, J. Avila, R. Brandt, and K.S. Kosik Brain Microtubule Associated Proteins 1997 Harwood Academic Publishers Amsterdam 113 124
64. M.L. Garcia Gil, M.A. Moran, and P. Gomez-Ramos Ubiquitinated granular structures and initial neurofibrillary changes in the human brain J. Neurol. Sci. 192 2001 27 34
65. S.M. Rosso, W. Kamphorst, B. de Graaf, R. Willemsen, R. Ravid, M.F. Niermeijer, M.G. Spillantini, P. Heutink, and J.C. van Swieten Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22 Brain 124 2001 1948 1957
66. G. Lee, R.L. Neve, and K.S. Kosik The microtubule binding domain of tau protein Neuron 2 1989 1615 1624
67. B.L. Goode, and S.C. Feinstein Identification of a novel microtubule binding and assembly domain in the developmentally regulated inter-repeat region of tau J. Cell Biol. 124 1994 769 782
68. K. Kosik, L. Orecchio, S. Bakalis, and R. Neve Developmentally regulated expression of specific tau sequences Neuron 2 1989 1389 1397
69. M. Goedert, M.G. Spillantini, R. Jakes, D. Rutherford, and R.A. Crowther Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease Neuron 3 1989 519 526
70. B.L. Goode, P.E. Denis, D. Panda, M.J. Radeke, H.P. Miller, L. Wilson, and S.C. Feinstein Functional interactions between the proline-rich and repeat regions of tau enhance microtubule binding and assembly Mol. Biol. Cell 8 1997 353 365
71. M. Morishima-Kawashima, M. Hasegawa, K. Takio, M. Suzuki, H. Yoshida, K. Titani, and Y. Ihara Proline-directed and non-proline-directed phosphorylation of PHF-tau J. Biol. Chem. 270 1995 823 829
72. K. Ishiguro Tau protein kinases RB J. Avila K.S. Kosik Brain Microtubule Associated Proteins 1997 Harwood Academic Publishers Amsterdam 73 93
73. A. Ferreira, Q. Lu, L. Orecchio, and K.S. Kosik Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta Mol. Cell. Neurosci. 9 1997 220 234
74. D.H. Geschwind Tau phosphorylation, tangles, and neurodegeneration: the chicken or the egg? Neuron 40 2003 457 460
75. T. Fath, J. Eidenmuller, and R. Brandt Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease J. Neurosci. 22 2002 9733 9741
76. W. Noble, V. Olm, K. Takata, E. Casey, O. Mary, J. Meyerson, K. Gaynor, J. LaFrancois, L. Wang, T. Kondo, P. Davies, M. Burns, Veeranna, R. Nixon, D. Dickson, Y. Matsuoka, M. Ahlijanian, L.F. Lau, and K. Duff Cdk5 is a key factor in tau aggregation and tangle formation in vivo Neuron 38 2003 555 565
77. J.C. Cruz, H.C. Tseng, J.A. Goldman, H. Shih, and L.H. Tsai Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles Neuron 40 2003 471 483
78. Y.C. Liou, A. Sun, A. Ryo, X.Z. Zhou, Z.X. Yu, H.K. Huang, T. Uchida, R. Bronson, G. Bing, X. Li, T. Hunter, and K.P. Lu Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration Nature 424 2003 556 561
79. Q. Tian, and J. Wang Role of serine/threonine protein phosphatase in Alzheimer's disease NeuroSignals 11 2002 262 269
80. N.E. Price, B. Wadzinski, and M.C. Mumby An anchoring factor targets protein phosphatase 2A to brain microtubules Brain Res. Mol. Brain Res. 73 1999 68 77
81. L. Sun, S.Y. Liu, X.W. Zhou, X.C. Wang, R. Liu, Q. Wang, and J.Z. Wang Inhibition of protein phosphatase 2A- and protein phosphatase 1-induced tau hyperphosphorylation and impairment of spatial memory retention in rats Neuroscience 118 2003 1175 1182
82. C.X. Gong, T. Lidsky, J. Wegiel, I. Grundke-Iqbal, and K. Iqbal Metabolically active rat brain slices as a model to study the regulation of protein phosphorylation in mammalian brain Brain Res. Brain Res. Protoc. 6 2001 134 140
83. H.M. Chung, and G. Struhl Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila Nat. Cell Biol. 3 2001 1129 1132
84. K. Spittaels, C. Van den Haute, J. Van Dorpe, H. Geerts, M. Mercken, K. Bruynseels, R. Lasrado, K. Vandezande, I. Laenen, T. Boon, J. Van Lint, J. Vandenheede, D. Moechars, R. Loos, and F. Van Leuven Glycogen synthase kinase-3beta phosphorylates protein tau and rescues the axonopathy in the central nervous system of human four-repeat tau transgenic mice J. Biol. Chem. 275 2000 41340 41349
85. H.Y. Zoghbi, and J. Botas Mouse and fly models of neurodegeneration Trends Genet. 18 2002 463 471
86. G.F. Hall, J. Yao, and G. Lee Human tau becomes phosphorylated and forms filamentous deposits when overexpressed in lamprey central neurons in situ Proc. Natl. Acad. Sci. U. S. A. 94 1997 4733 4738
87. C.W. Wittmann, M.F. Wszolek, J.M. Shulman, P.M. Salvaterra, J. Lewis, M. Hutton, and M.B. Feany Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles Science 14 2001 14
88. M. Goedert, R. Jakes, M.G. Spillantini, M. Hasegawa, M.J. Smith, and R.A. Crowther Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulfated glycosaminoglycans Nature 383 1996 550 553
89. N. Rao, I. Dodge, and H. Band The Cbl family of ubiquitin ligases: critical negative regulators of tyrosine kinase signaling in the immune system J. Leukoc. Biol. 71 2002 753 763
90. H. Shimura, D. Schwartz, S.P. Gygi, and K.S. Kosik CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival J. Biol. Chem. 279 2004 4869 4876
91. C. Joachim, J. Morris, D. Selkoe, and K. Kosik Tau epitopes are incorporated into a range of lesions in Alzheimer's disease J. Neuropathol. Exp. Neurol. 46 1987 611 622
92. K.S. Kosik, L.D. Orecchio, L. Binder, J.Q. Trojanowski, V.M.-Y. Lee, and G. Lee Epitopes that span the tau molecule are shared with paired helical filaments Neuron 1 1988 817 825
93. M.C. Bennett, J.F. Bishop, Y. Leng, P.B. Chock, T.N. Chase, and M.M. Mouradian Degradation of alpha-synuclein by proteasome J. Biol. Chem. 274 1999 33855 33858
94. K. Ancolio, C. Alves da Costa, K. Ueda, and F. Checler Alpha-synuclein and the Parkinson's disease-related mutant Ala53Thr-alpha-synuclein do not undergo proteasomal degradation in HEK293 and neuronal cells Neurosci. Lett. 285 2000 79 82
95. H.J. Rideout, K.E. Larsen, D. Sulzer, and L. Stefanis Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells J. Neurochem. 78 2001 899 908
96. H.J. Rideout, and L. Stefanis Proteasomal inhibition-induced inclusion formation and death in cortical neurons require transcription and ubiquitination Mol. Cell. Neurosci. 21 2002 223 238
97. C.X. Gong, J. Wegiel, T. Lidsky, L. Zuck, J. Avila, H.M. Wisniewski, I. Grundke-Iqbal, and K. Iqbal Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain Brain Res. 853 2000 299 309
98. E. Sontag, V. Nunbhakdi-Craig, G. Lee, R. Brandt, C. Kamibayashi, J. Kuret, C.L. White III, M.C. Mumby, and G.S. Bloom Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies J. Biol. Chem. 274 1999 25490 25498
99. S.G. Greenberg, P. Davies, J.D. Schein, and L.I. Binder Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau J. Biol. Chem. 267 1992 564 569
100. J. Biernat, E.-M. Mandelkow, C. Schroter, B. Lichtenberg-Kraag, B. Steiner, B. Berling, H. Meyer, M. Mercken, M. Vandermeeren, and M. Goedert The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region EMBO J. 11 1992 1593 1597
101. A. Castegna, M. Aksenov, V. Thongboonkerd, J.B. Klein, W.M. Pierce, R. Booze, W.R. Markesbery, and D.A. Butterfield Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71 J. Neurochem. 82 2002 1524 1532
102. H. Gonen, C.E. Smith, N.R. Siegel, C. Kahana, W.C. Merrick, K. Chakraburtty, A.L. Schwartz, and A. Ciechanover Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu Proc. Natl. Acad. Sci. U. S. A. 91 1994 7648 7652
103. D.R. Thai Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease Brain Pathol. 12 2002 405 411
104. J. Jiang, C.A. Ballinger, Y. Wu, Q. Dai, D.M. Cyr, J. Hohfeld, and C. Patterson CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation J. Biol. Chem. 276 2001 42938 42944
105. G.C. Meacham, C. Patterson, W. Zhang, J.M. Younger, and D.M. Cyr The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation Nat. Cell Biol. 3 2001 100 105
106. P. Zhou, N. Fernandes, I.L. Dodge, A.L. Reddi, N. Rao, H. Safran, T.A. DiPetrillo, D.E. Wazer, V. Band, and H. Band ErbB2 degradation mediated by the co-chaperone protein CHIP J. Biol. Chem. 278 2003 13829 13837
107. J. Demand, S. Alberti, C. Patterson, and J. Hohfeld Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling Curr. Biol. 11 2001 1569 1577
108. S. Murata, Y. Minami, M. Minami, T. Chiba, and K. Tanaka CHIP is a chaperone-dependent E3 ligase that ubiquitylates unfolded protein EMBO Rep. 2 2001 1133 1138
109. I. Dominguez, K. Itoh, and S.Y. Sokol Role of glycogen synthase kinase 3 beta as a negative regulator of dorsoventral axis formation in Xenopus embryos Proc. Natl. Acad. Sci. U. S. A. 92 1995 8498 8502
110. F. Dou, W.J. Netzer, K. Tanemura, F. Li, F.U. Hartl, A. Takashima, G.K. Gouras, P. Greengard, and H. Xu Chaperones increase association of tau protein with microtubules Proc. Natl. Acad. Sci. U. S. A. 100 2003 721 726
111. L. Petrucelli, D. Dickson, K. Kehoe, J. Taylor, H. Snyder, A. Grover, M. De Lucia, E. McGowan, J. Lewis, G. Prihar, J. Kim, W.H. Dillmann, S.E. Browne, A. Hall, R. Voellmy, Y. Tsuboi, T.M. Dawson, B. Wolozin, J. Hardy, and M. Hutton CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation Hum. Mol. Genet. 13 2004 703 714
112. Y. Imai, M. Soda, S. Hatakeyama, T. Akagi, T. Hashikawa, K.I. Nakayama, and R. Takahashi CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity Mol. Cell 10 2002 55 67
113. J. Luders, J. Demand, and J. Hohfeld The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome J. Biol. Chem. 275 2000 4613 4617
114. T.C. Gamblin, F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A.L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. LaPointe, R. Miller, R.W. Berry, L.I. Binder, and V.L. Cryns Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 100 2003 10032 10037
115. K. Kobayashi, H. Nakano, M. Hayashi, M. Shimazaki, Y. Fukutani, K. Sasaki, K. Sugimori, and Y. Koshino Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease J. Neurol. Sci. 208 2003 17 24
116. C.G. Concannon, A.M. Gorman, and A. Samali On the role of Hsp27 in regulating apoptosis Apoptosis 8 2003 61 70
117. D.C. David, R. Layfield, L. Serpell, Y. Narain, M. Goedert, and M.G. Spillantini Proteasomal degradation of tau protein J. Neurochem. 83 2002 176 185
118. G.K. Tofaris, R. Layfield, and M.G. Spillantini Alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome FEBS Lett. 509 2001 22 26
119. A.F. Kisselev, T.N. Akopian, K.M. Woo, and A.L. Goldberg The sizes of peptides generated from protein by mammalian 26 and 20 S proteasomes. Implications for understanding the degradative mechanism and antigen presentation J. Biol. Chem. 274 1999 3363 3371
120. R. Touitou, J. Richardson, S. Bose, M. Nakanishi, J. Rivett, and M.J. Allday A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome EMBO J. 20 2001 2367 2375
121. M. Zhang, C.M. Pickart, and P. Coffino Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin-independent substrate EMBO J. 22 2003 1488 1496
122. A.M. Krueger-Naug, J.C. Plumier, D.A. Hopkins, and R.W. Currie Hsp27 in the nervous system: expression in pathophysiology and in the aging brain Prog. Mol. Subcell. Biol. 28 2002 235 251
123. V. Vleminckx, P. Van Damme, K. Goffin, H. Delye, L. Van Den Bosch, and W. Robberecht Upregulation of HSP27 in a transgenic model of ALS J. Neuropathol. Exp. Neurol. 61 2002 968 974
124. J.C. Plumier, J.N. Armstrong, J. Landry, J.M. Babity, H.A. Robertson, and R.W. Currie Expression of the 27,000 mol. wt heat shock protein following kainic acid-induced status epilepticus in the rat Neuroscience 75 1996 849 856
125. J.C. Plumier, J.N. Armstrong, N.I. Wood, J.M. Babity, T.C. Hamilton, A.J. Hunter, H.A. Robertson, and R.W. Currie Differential expression of c-fos, Hsp70 and Hsp27 after photothrombotic injury in the rat brain Brain Res. Mol. Brain Res. 45 1997 239 246
126. C.L. Armstrong, A.M. Krueger-Naug, R.W. Currie, and R. Hawkes Constitutive expression of heat shock protein HSP25 in the central nervous system of the developing and adult mouse J. Comp. Neurol. 434 2001 262 274
127. D.A. Hopkins, J.C. Plumier, and R.W. Currie Induction of the 27-kDa heat shock protein (Hsp27) in the rat medulla oblongata after vagus nerve injury Exp. Neurol. 153 1998 173 183
128. M.J. Wagstaff, Y. Collaco-Moraes, J. Smith, J.S. de Belleroche, R.S. Coffin, and D.S. Latchman Protection of neuronal cells from apoptosis by Hsp27 delivered with a herpes simplex virus-based vector J. Biol. Chem. 274 1999 5061 5069
129. S.E. Lewis, R.J. Mannion, F.A. White, R.E. Coggeshall, S. Beggs, M. Costigan, J.L. Martin, W.H. Dillmann, and C.J. Woolf A role for HSP27 in sensory neuron survival J. Neurosci. 19 1999 8945 8953
130. S.C. Benn, D. Perrelet, A.C. Kato, J. Scholz, I. Decosterd, R.J. Mannion, J.C. Bakowska, and C.J. Woolf Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival Neuron 36 2002 45 56
131. A. Wyttenbach, O. Sauvageot, J. Carmichael, C. Diaz-Latoud, A.P. Arrigo, and D.C. Rubinsztein Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin Hum. Mol. Genet. 11 2002 1137 1151
132. A. Singleton, A. Myers, and J. Hardy The law of mass action applied to neurodegenerative disease: a hypothesis concerning the etiology and pathogenesis of complex diseases Hum. Mol. Genet. 13 Spec. No. 1 2004 R123 R126
133. A.B. Singleton, M. Farrer, J. Johnson, A. Singleton, S. Hague, J. Kachergus, M. Hulihan, T. Peuralinna, A. Dutra, R. Nussbaum, S. Lincoln, A. Crawley, M. Hanson, D. Maraganore, C. Adler, M.R. Cookson, M. Muenter, M. Baptista, D. Miller, J. Blancato, J. Hardy, and K. Gwinn-Hardy Alpha-synuclein locus triplication causes Parkinson's disease Science 302 2003 841
134. M. Farrer, J. Kachergus, L. Forno, S. Lincoln, D.S. Wang, M. Hulihan, D. Maraganore, K. Gwinn-Hardy, Z. Wszolek, D. Dickson, and J.W. Langston Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications Ann. Neurol. 55 2004 174 179
135. C. Queitsch, T.A. Sangster, and S. Lindquist Hsp90 as a capacitor of phenotypic variation Nature 417 2002 618 624
136. S.L. Rutherford, and S. Lindquist Hsp90 as a capacitor for morphological evolution Nature 396 1998 336 342
137. P. Kazemi-Esfarjani, and S. Benzer Genetic suppression of polyglutamine toxicity in Drosophila Science 287 2000 837 840